Delivery Order SPE2DB22D3401-SPE2DB25FT6FJ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,899.74 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract action under...
- The Defense Logistics Agency awarded a $6,441.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units). This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement extending through December 2026. The order will be fulfilled from the contractor's...
- The Defense Logistics Agency awarded a $1,562.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Nucynta ER 150 mg tablets (60-count units). This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The prime vendor contract serves as a comprehensive global pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,944.08 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count packages) with a completion date of August 11, 2025. This competitively awarded, non-set-aside contract operates under a firm fixed price arrangement and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,617.25 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 200 mg tablets (60-count units) on June 2, 2025, with completion scheduled for June 3, 2025. This firm fixed price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,367.15 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count) on August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the awardee's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $3,614.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Nucynta ER 100 mg tablets (60-count bottles). This is a non-set-aside contract with an ultimate completion date of September 18, 2025. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $4,416.12 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count packages) on August 20, 2025, with a completion date of August 21, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Nucynta ER 150 mg tablets (60-count units) with a ceiling value of $1,110.11. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's...
- This delivery order, awarded on June 4, 2025, by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, provides for the supply of Nucynta ER 150 mg tablets (60-count units) with a ceiling value of $2,849.58 under firm fixed pricing. The order is not set-aside and represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. AmerisourceBergen Drug Corp, a major healthcare solutions provider and critical vendor for federal...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT6FJDelivery Order
The Defense Logistics Agency awarded a $3,796.74 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Nucynta ER 200 mg tablets (60-count units). This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement valued through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location. AmerisourceBergen Drug Corp serves as a critical vendor within the federal medical supply chain, providing a comprehensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's extensive contract history with DLA demonstrates its capability to meet federal procurement requirements across multiple therapeutic domains, including pain management medications such as Nucynta ER. The underlying SPE2DX prime vendor contract enables AmerisourceBergen to supply brand-name and generic drugs, specialty medications, and related medical commodities globally to customers including the Defense Health Agency and U.S. Coast Guard through a flexible contracting vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 9/16/25 |